The fully enrolled placebo-controlled Phase 3 trial is evaluating NurOwn® investigational treatment in ALS patients...
Denver, Colorado, May 19, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — CBD Global Sciences Inc....
FRISCO, Texas, April 06, 2020 (GLOBE NEWSWIRE) — Ecoark Holdings, Inc. (“Ecoark”) (OTC: ZEST), announced...
Experience Developing, Seeking Regulatory Approval of and Commercializing Multi-Billion Dollar Neurology Therapies NEW YORK, May 27,...
VANCOUVER, British Columbia, May 21, 2020 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE:SHRC) (FSE:IWIA) (OTCQB:INTWF)...
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antiviral/antibacterial,...
